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Reactive oxygen species are important in carcinogenesis, di eases, and aging, probably through oxidative damage of 
DNA. Our understanding of this relationship atthe molecular level is very sketchy. It has recently been found that in 
mitoehondria oxidative DNA damage is particularly high and may not be repaired efficiently. I propose that oxidatively 
generated DNA fragments e cape from mitochondria and become integrated into the nuclear genome.This may transform 
cells to a cancerous state. Time-dependent nuclear accumulation f mitochondrial DNA fragments may progressively 
change the nuclear information content and thereby cause aging. This proposal can be tested experimentally. 
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1. OXYGEN IN CANCER AND AGING 
Reactive oxygen species such as the superoxide 
radical (O~-), hydrogen peroxide (HzO2), the 
hydroxyl radical (OH') and singlet oxygen are pro- 
duced by normal metabolism, irradiation, or some 
chemicals including tumor promotors. The very 
aggressive OH" is mainly formed by reducing H202 
with O~- and heavy metal ions. There is evidence 
that reactive oxygen plays an important role in 
multistep carcinogenesis, diseases, and aging 
[1-7]. 
Agents which catalytically destroy reactive ox- 
ygen species [6,8] and serve as antioxidants 
[7,9,10] inhibit various steps in neoplastic transfor- 
mation and defend cells in a manner which may 
vary among species and tissues [8,11,12]. For ex- 
ample, superoxide dismutase [8], catalase [11], 
vitamin A analogues [12] and vitamin C [13] sup- 
press cell transformation and, in some cases, in- 
hibit the action of some tumor promotors 
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[8,12,14]. Evidence for the participation of reac- 
tive oxygen in carcinogenesis also found by 
relating cancer, metabolic rate and life span in 
various species [15]. Thus, the cumulative cancer 
risk increases with about the fourth power of age 
in short-lived species (about 30% of rodents have 
cancer by the end of their 2-3 year life span) and 
in long-lived species (about 30°7o f humans have 
cancer by the end of their 85 year life span). 
Cancer has in this context been considered as the 
price to be paid for longevity. 
Aging has been defined as the progressive ac- 
cumulation of changes with time associated with or 
responsible for the ever-increasing susceptibility to 
diseases and death which accompanies advancing 
age [16]. Several theories of aging have been pro- 
posed including that of DNA alterations, lower ac- 
curacy of protein synthesis ('error catastrophe'), 
cross-linking of macromolecules, and failure of the 
immune system. Yet, our understanding of aging 
at the molecular level is nil, and aging research is 
still in a phenomenological phase. The free radical 
theory of aging [16,17] has received much atten- 
tion since reactive oxygen species can damage com- 
pounds of fundamental biological importance. 
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Consistent with it are the increase in life span upon 
food restriction [18,19] and the high levels of an- 
tioxidants in humans which may have facilitated 
the evolution of man's longevity [20-23]. The im- 
portant factor responsible for longevity appears to 
be the basal metabolic rate [24,25], i.e. the quanti- 
ty of oxygen consumed (on a body weight basis), 
which is higher in short-lived than in long-lived 
animals. The free radical theory of aging has 
recently been criticized by Pryor [26] who suggests 
that reactive oxygen may act indirectly by causing 
the age-related increase in diseases, such as 
diabetes, cataracts, and rheumatism. 
The critical targets of reactive oxygen which may 
be affected during carcinogenesis and aging have 
not yet been identified with certainty. Because it 
carries the information between generations of 
somatic cells, DNA has been given greatest at- 
tention. 
2. OXIDATIVE DAMAGE TO DNA AND ITS 
RELATIONSHIP TO CANCER AND AGING 
Oxidative damage to DNA could be a major fac- 
tor in cancer and aging [7,24,25,28]. Damage is 
caused by reactive oxygen species, lipid hydro- 
peroxides and their radical and aldehydic degrada- 
tion products [29,30], and oxidation products of 
aromatic amino acids and purines. Hyperbaric 
oxygen induces mutations in bacteria [31] and 
chromosomal aberrations in eukaryotic cells 
[32,33], probably because the amount of reactive 
oxygen produced by cellular metabolism in this 
situation is increased [34]. Indeed, O~ and H202 
mutagenize bacteria and induce DNA breaks and 
chromosomal aberrations [35,36]. Characteristic 
DNA lesions are single- and double-strand breaks, 
apurinic and apyrimidinic sites, and products of 
the 5,6-dihydroxydihydrothymine type. O~- in- 
duces strand breaks in intracellular DNA [37,38] 
and liberates nucleobases from nucleotides [39]. 
Oxygen-dependent DNA damage is also observed 
with aflatoxin B~ [40] and phorbol esters [41,42]. 
The formation of thymine glycol and thymidine 
glycol in vivo has been used as a possible assay for 
oxidative DNA damage [28,43]. Very recently, the 
formation of 8-hydroxydeoxyguanosine in DNA 
by oxygen radicals was reported [44-49]. 
Several models relate oxidative DNA damage to 
aging and cancer [28]. For example, free radicals 
could react with nuclear DNA and produce 
somatic mutations including point or frameshift 
mutations, deletions, and strand breaks. Even 
without causing a mutagenic event, oxidative DNA 
damage may lead to cancer and aging, for example 
by inducing loss of 5-methylcytosine since 
methylation of cytosine may be important in turn- 
ing off genes in differentiation [50]. This type of 
damage would be particularly important for ter- 
minally differentiated cells that do not normally 
undergo DNA replication. 
3. MITOCHONDRIA AND OXYGEN 
Mitochondria consume about 90°7o of the cell's 
oxygen, and the mitochondrial respiratory chain is 
the source of a continuing flux of oxygen radicals 
[34,51]. Superoxide production in mitochondria 
increases with advancing age [52]. In man about 
2 × 102° molecules 02 are reduced per g of tissue 
per day. If only 3 parts per 10 s of this oxygen form 
OH" this would be equivalent o an exposure of 
1 rad ionizing radiation [27]. Thus, endogenously 
produced oxygen radicals pose a major threat to 
aerobically living organisms. This can also be il- 
lustrated by another calculation: A rat has a 
roughly 6-fold higher basal metabolic rate than 
man. Assuming 1000 mitochondria per cell and a 
yield of 1% O~- from O2 consumed in mitochon- 
dria [34] it follows that about 10 7 O2- are form- 
ed/mitochondrion per day in a rat weighing 75 g. 
Despite the presence of antioxidants in mitochon- 
dria, a considerable amount of OH" may therefore 
be produced. The steady-state concentration of ox- 
ygen radicals may be even higher in tumor 
mitochondria since they have diminished amounts 
of superoxide dismutase [53,54]. 
4. MITOCHONDRIAL DNA 
Mitochondria possess their own DNA. It is pre- 
sent in multiple copies of double-stranded super- 
coiled circular molecules which are not covered by 
histones. During evolution, the size of the 
mitochondrial genome became progressively 
smaller. It contains about 16500 base pairs in 
mammals where it codes for a set of 37 genes peci- 
fying 22 tRNAs, 13 mRNAs, and 2 rRNAs. The 
mitochondrial genome evolves 5-10-times faster 
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than the nuclear genome of the same organism 
[551. 
There is a general consensus that mitochondria 
are less efficient in repairing DNA damage and 
replication errors than the nucleus [56-59]. For ex- 
ample, they lack excision repair and recombina- 
tional repair [60,61]. Mitochondria do, however, 
possess three uracil DNA glycosylases [62-64], 
two endonuclease activities specific for apurinic/ 
apyrimidinic sites [Tomkinson, A.E. et al. (1988) 
submitted], endonucleases that act on lesions in- 
troduced by high UV doses (Tomkinson, A.E., 
personal communication), and a DNA ligase [65]. 
It is reasonable to suppose that these enzymes par- 
ticipate in DNA repair and replication though 
some of them may also have a role in eliminating 
damaged DNA molecules. 
8-Hydroxydeoxyguanosine is present in DNA 
isolated from normal rat liver mitochondria t 
16-times the level of nuclear DNA [49]. The total 
oxidative damage of mitochondrial DNA must be 
very high, since 8-hydroxydeoxyguanosine is just 
one of several oxidized bases which are formed 
when OH" reacts with DNA [66]. Besides oxidizing 
DNA bases, the indiscriminately reacting OH" also 
causes DNA strand breaks [67]. Indeed, this type 
of damage is also seen in mitochondrial DNA. For 
example, adriamycin which damages nuclear DNA 
in an oxygen-dependent manner, also causes 
strand breaks in mitochondrial DNA of rat heart 
in vivo [68. Bleomycin introduces nicks in 
mitochondrial DNA of mouse fibroblasts [69], and 
DNA of isolated liver, lung and tumor mitochon- 
dria in an oxygen-dependent manner [70]. Also 
prooxidants like alloxan and t-butyl hydroperoxide 
fragment mitochondrial DNA of rat liver (Richter, 
C., unpublished). The high steady state of ox- 
idative damage in mitochondrial DNA is most like- 
ly due to a copious flux of oxygen radicals, 
inefficient repair, and the nakedness of mitochon- 
drial DNA. 
5. HYPOTHESIS 
The large number of mitochondrial DNA copies 
in most cells and the massive oxidative damage 
comprising oxidized bases and strand breaks 
together with the inefficient repair suggest the 
presence of an appreciable amount of DNA 
fragments in mitochondria in vivo. Some of these 
fragments may escape from the organelle and 
become integrated into the nuclear DNA. The 
mechanism of DNA transfer from mitochondria to 
the nucleus and its insertion into the nuclear 
genome is a matter of speculation. It is important 
to note, however, that reactive oxygen species 
destabilize biological membranes [71] and thereby 
may facilitate the escape of DNA from mitochon- 
dria. The subsequent route may be analogous to 
the insertion of viral or bacterial DNA into nuclear 
DNA, a common phenomenon i nature. 
Integration of mitochondrial DNA fragments 
into the nuclear genome may transform the cell. 
This could be due to a variety of events. Genes 
responsible for the maintenance of normal growth 
control might become inactivated by insertional 
mutagenesis. A proto-oncogene might be activated 
by a promotor insertion mechanism. These events 
require that the mitochondrial DNA fragments be 
inserted at particular sites in the nuclear DNA. 
Alternatively, mitochondrial DNA fragments con- 
taining oxidatively damaged sites might be inserted 
randomly into the nuclear genome. There they may 
trigger the induction of DNA repair enzymes, 
some of which are error prone [72-74]. If such 
repair was sustained for several cell cycles a pro- 
mutagenic state could be established [5,75,76]. 
This mechanism (the induction of sustained, error- 
prone DNA repair) might affect a far greater pro- 
portion of the transfected cells than a mechanism 
requiring the insertion of specific sequences 
and/or  insertion at specific sites. Finally, just ran- 
dom insertion of undamaged DNA fragments 
might hit an appropriate target, for example a sup- 
pressor gene. 
The time-dependent accumulation of 'foreign' 
mitochondrial sequences could also lead to pro- 
gressive changes in the information content of the 
nuclear genome and thereby to aging. This may be 
facilitated by the activities of nuclear repair en- 
zymes because integrated and repaired mitochon- 
drial DNA fragments may no longer be recognized 
as 'foreign' and therefore be carried over to the 
next cell generation. 
Inter-organellar gene transfer has already been 
observed. There are reports on mitochondrial 
DNA sequences being present simultaneously in
nuclear and mitochondrial DNA of several species 
('promiscuous DNA') (see [77] for a review). These 
findings strongly suggest that genetic exchange be- 
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tween mitochondria nd nuclei has occurred con- 
tinuously during evolution. The exciting possibility 
of transfer of mitochondrial DNA sequences into 
the nuclear genome during the life-cycle of the 
fungus, Podospora nserina, and its possible role 
in senescence [78,79] are presently not proven [80]. 
Alterations in mitochondrial functions, e.g. 
maintenance of ion homeostasis or ATP supply, 
have repeatedly been suggested to contribute to 
cellular transformation since tumor cell mitochon- 
dria can differ structurally and functionally from 
those of normal cells (see [811 for a review), but 
clear evidence in favour of this suggestion is lack- 
ing. There is, however, evidence that some 
chemical carcinogens primarily attack mitochon- 
dria [82-91]. It has also been proposed that 
mitochondria are the 'molecular clock' in 
eukaryotes [92] and that mitochondrial genetic 
damage is one of the fundamental mechanisms 
underlying aging [93,94]. 
Most studies in the field of aging are descriptive, 
and most theories of aging have been difficult to 
test directly experimentally. The proposal that 
mitochondrial DNA fragments become incor- 
porated into the nuclear genome and thereby con- 
tribute to cancer and aging can be tested with the 
powerful techniques of molecular biology. 
Hepatoma cells from hemochromatosis patients 
may be a good starting material, since iron ions 
catalyse oxidative mitochondrial DNA damage 
[49]. Cells in culture with their finite life span, in 
terms of the numbers of divisions they can 
undergo, could be used to test the proposal with 
respect o aging. 
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